Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
Pemafibrate is used in the treatment of hyperlipidemia. It also functions as a promising selective PPAR-α modulator for treatment of combined dyslipidemia phase 2 clinical trials with K-877.